No Alterations in the Frequency of FOXP3+ Regulatory T-Cells in Type 1 DiabetesTodd M. Brusko, Mark A. Atkinson, Clive Wasserfall et al.|Diabetes|2007Cited by 253
Type 1 Diabetes Mellitus: Etiology, Presentation, and ManagementMichael J. Haller, Desmond Schatz, Mark A. Atkinson|Pediatric Clinics of North America|2005Cited by 214
Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 DiabetesMichael J. Haller, W. J. Russell, William E. Russell et al.|Diabetes Care|2018Cited by 183
Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetesMichael J. Haller, Desmond Schatz, Stephen E. Gitelman et al.|Journal of Clinical Investigation|2014Cited by 164
Radial Artery Tonometry Demonstrates Arterial Stiffness in Children With Type 1 DiabetesMichael J. Haller, Janet Silverstein, Margaret M. Samyn et al.|Diabetes Care|2004Cited by 159